AdaptVac to lead international filovirus vaccine project with CEPI and EU funding
NOME portfolio company AdaptVac will coordinate a global consortium developing a vaccine candidate targeting multiple filoviruses, including Ebolavirus Zaire, Sudan Ebolavirus and Marburg virus. The project is supported by $12.4 million in funding from CEPI and the European Union’s Horizon ...